Live tape
Top 8, mentions 7d11,446SPCX2,425 mentions▲ +0.08GOOGL1,984 mentions▲ +0.02META1,790 mentions▲ +0.04TSLA1,703 mentions▲ +0.05NFLX973 mentions▲ +0.03QQQ886 mentions▲ +0.05AMZN843 mentions▲ +0.06NVDA842 mentions▲ +0.06

Equity · Healthcare

RAPP

NASDAQ

Rapport Therapeutics (RAPP)

$25.90 −4.07% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 23, 2026

Reddit mentioned RAPP 2 times in the 30 days to 26 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 26 October 2026.

Price · Chart
31 sessions
$60 $20 4 Aug 23 Oct

The line runs $42 on 4 August through $25.90 on 23 October, on a scale from $20 to $60. Days the market did not trade hold the previous close, flat.

Market cap $1.2B
52-week range $24 – $52
Avg volume 46.4K
Mentions · 30d 2

as of Oct 23, 2026

Rapport Therapeutics (RAPP) · crowd attention × price

Share ↗
2 mentions

Day25 Oct 2026

MENTIONS10–2 / day
RAPP over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale.per day01227 Sep4 Oct12 Oct19 Oct26 Oct
RAPP over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale.27 Sep12 Oct26 Oct

Before our first record — not zero

The Distributed Sentinel 26 Oct 2026

RAPP drew 2 Reddit mentions over the 30 days to 26 October 2026

This chart in words

The chart plots daily Reddit mentions of RAPP over the 30 days to 26 October 2026: 2 in total, busiest on 24 October with 1, and 1 on the last day counted.

Rapport Therapeutics (RAPP) on Reddit · 30d

n = 2 scored · Method

In the 30 days to 26 Oct 2026, Rapport Therapeutics drew 2 Reddit mentions in the finance subreddits we track, 2 of them scored for sentiment.

2 mentions of RAPP were scored for sentiment in these 30 days, so each one carries 1/2 of any share. A split that coarse states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where RAPP is discussed

(30d)
r/stocks 100% 2 +0.11

Rapport Therapeutics (RAPP) insider trades

SEC Form 4 · last 90 days · newest reported trade 23 Oct 2026

In the 90 days to 26 Oct 2026, Rapport Therapeutics insiders reported 12 open-market sales and 6 purchases (SEC Form 4).

Open-market buys 6
Open-market sells 12
Net sold $5.26M
Non-trade filings 0
Date Insider Type Shares Value
23 Oct 2026 Sanchez Ramiro Director Buy 3,600 $98K
22 Oct 2026 MARAGANORE JOHN Director Buy 9,411 $249K
22 Oct 2026 PAUL STEVEN M Director Buy 35,714 $974K
22 Oct 2026 Young Wendy B. Director Buy 3,789 $100K
22 Oct 2026 Silva Paul M Director Buy 3,680 $100K
21 Oct 2026 Ignelzi Troy A. Chief Financial Officer Buy 5,500 $144K
21 Oct 2026 Ceesay Abraham Chief Executive Officer Sell 2,210 $64K
07 Oct 2026 Ceesay Abraham Chief Executive Officer Sell 1,147 $35K
06 Oct 2026 Ceesay Abraham Chief Executive Officer Sell 3,375 $108K
30 Sep 2026 Gault Cheryl Chief Operating Officer Sell 10,000 $332K
23 Sep 2026 Ceesay Abraham Chief Executive Officer Sell 2,210 $87K
08 Sep 2026 Ceesay Abraham Chief Executive Officer Sell 8,210 $374K

Showing the 12 most recent of 18 open-market trades in this window. The figures above count all of them.

Rapport Therapeutics (RAPP) reported financials

SEC EDGAR XBRL SEC EDGAR

Rapport Therapeutics reported net income of −$111.5M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$111.5M 31 Dec 2025 fiscal year
Diluted EPS −$2.86 31 Dec 2025 fiscal year
Total assets $459.0M 30 Jun 2026 at period end
Total equity $422.9M 30 Jun 2026 at period end

Rapport Therapeutics (RAPP) earnings

SEC EDGAR

Rapport Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$1.19; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.19 —
31 Mar 2026 Q1 2026 −$0.42 $20M
31 Dec 2025 FY 2025 −$2.86 —
30 Sep 2025 Q3 2025 −$0.71 —
30 Jun 2025 Q2 2025 −$0.75 —
31 Mar 2025 Q1 2025 −$0.68 —
31 Dec 2024 FY 2024 −$3.78 —
30 Sep 2024 Q3 2024 −$0.50 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Rapport Therapeutics (RAPP) institutional holders (13F)

SEC Form 13F SEC EDGAR

6 of the 45 institutional funds we track reported a Rapport Therapeutics position for the quarter ended 30 Jun 2026 — a combined $85.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 1,547,090 $64.5M
D. E. Shaw & Co. Held (±25%) +22.4% shares 214,831 $9.0M
Millennium Management Trimmed −51.5% shares 154,908 $6.5M
Citadel Advisors New position 82,442 $3.4M
AQR Capital Management Held (±25%) +3.7% shares 26,454 $1.1M
Two Sigma Investments Held (±25%) −12.9% shares 24,470 $1.0M

Rapport Therapeutics (RAPP) fails-to-deliver

SEC CNS data SEC

On 18 Sep 2026, 29 shares of Rapport Therapeutics failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
18 Sep 2026 29 $1K <0.001%

Rapport Therapeutics (RAPP): frequently asked questions

From live data

Have Rapport Therapeutics insiders bought or sold shares recently?

In the 90 days to 26 Oct 2026, Rapport Therapeutics insiders reported 12 open-market sales and 6 purchases (SEC Form 4).

How many institutions hold Rapport Therapeutics?

6 of the 45 institutional funds we track reported a Rapport Therapeutics position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Rapport Therapeutics had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Rapport Therapeutics is dated 18 Sep 2026, when 29 shares failed to deliver.

When did Rapport Therapeutics last report earnings?

Rapport Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$1.19; no next date is announced in SEC filings yet.

What exchange is Rapport Therapeutics listed on?

Rapport Therapeutics trades on NASDAQ under the ticker RAPP.

What is Reddit saying about Rapport Therapeutics?

Rapport Therapeutics was mentioned 2 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of 2 classified mentions, 100% read bullish, 0% bearish and 0% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARValuation computed from SEC EDGAR filings